Ignite Creation Date:
2024-05-05 @ 5:18 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00425386
Status:
COMPLETED
Last Update Posted:
2017-05-03
First Post:
2007-01-19
Brief Title:
Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer
Sponsor:
Organization:
OHSU Knight Cancer Institute